Sentences with phrase «pharmacogenomics into»

One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public's awareness over the benefits of pharmacogenomics in rationalising drug use.

The Genomics and Pharmacogenomics Working Group aims to undertake and coordinate research projects that will facilitate the integration of genomics applications and pharmacogenomics into healthcare.

Not exact matches

For aspiring geneticists, the lesson of the two companies» transformations is that genetics is moving into the realm of the practical, with the promise of personalized medicine and pharmacogenomics.

«Young companies trying to get into pharmacogenomics and personalized medicine are facing daunting challenges because of uncertainties with FDA and just the inherent difficulties of trying to change the paradigm to something where side effects are unacceptable,» says Galas.

Facilitate the introduction of pharmacogenomics and advanced omics technologies into the mainstream clinical practice.

The Genomic Medicine Alliance activities are divided into 8 Working Groups, namely Genome Informatics, Pharmacogenomics, Cancer Genomics, Rare Diseases, Public Health Genomics, Economic evaluation in Genomic Medicine, Genethics, and Quality Assurance.

The goal of pre-emptive pharmacogenomics testing is to take into account the impact of each individual's genetic variants when selecting therapy thus providing personalized medicine.

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learPharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learpharmacogenomics, its clinical translation and educational and learning activities.

In furtherance of their mutual interest in improving fundamental and clinical pharmacogenomics and its translation into clinical practice, the two organizations have agreed: (a) cooperate and collaborate on programs and activities of mutual interest, (b) work together to provide education symposia / workshops in developing countries and regions, and (c) foster collaborative research to better understand the genetic basis for ethnic diversity in the response to and adverse effects from medicines.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing range of products and services — in gene discovery, pharmaceuticals, DNA - based diagnostics, pharmacogenomics, in silico discovery tools, bioinformatics and medical decision support systems.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing pipeline of products and services — in pharmaceuticals, gene and drug discovery, DNA - based diagnostics, pharmacogenomics, bioinformatics, and clinical trials.

Author, «FDA Approval of BiDil: First Step to Pharmacogenomics or Detour into Race - based Medicine?»